Keywords: cordis, drug-eluting, stent, get, incremental, reimbursement, subsidiary

Cordis' drug-eluting stent to get incremental reimbursement

Article | 05 August 2002

Print This

In what Cordis, a subsidiary of Johnson & Johnson, describes as a"precedent-setting decision" by the US Department of Health and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in